Pay in 4 interest-free payments of $6.69 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
Linge J et al
For someone who needs to lose 50+ pounds or has obesity-related health conditions, GLP-1 medications typically offer a better risk-benefit profile
But for HR and benefits leaders at self-insured employers, this excitement brings new challenges: Rising demand from employees who want GLP-1s Shifting coverage rules from PBMs and new FDA indications Soaring costs that are straining even the best-managed benefit plans Multiplying cash-pay options fueling more confusion Growing member frustration when answers arent clear We give you & your members answersfrom a trusted source Scriptas GLP-1 Navigator delivers independent, always-current trusted insights in a centralized guide so you can guide members to The Right Meds at the Best Price
Comparative Cardiovascular Effectiveness of Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors in Diabetes Mellitus
